Navigation Links
VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009
Date:11/4/2009

SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "VIA-3196, a Liver-directed Thyroid Beta Agonist for Treating Cardiometabolic Disease" in the Abstract Oral Session on Novel Biological Mechanisms of Atherosclerosis November 17, 2009 at the American Heart Association Scientific Sessions 2009 in Orlando, Florida.

    The presentation details are as follows:

      Date / Time:  Tuesday November 17, 2009
                    9:15 am ET
      Location:     Orange County Convention Center, Orlando, Florida
                    Room W304cd
      Session:      Abstract Oral Session - Novel Biological Mechanisms of
                    Atherosclerosis
      Title:        VIA-3196, a Liver-directed Thyroid Beta Agonist for
                    Treating Cardiometabolic Disease

About THR beta agonist

VIA-3196 is an orally administered, small-molecule beta-selective thyroid hormone receptor agonist designed to specifically target receptors in the liver involved in metabolism and cholesterol regulation, and avoid side effects associated with thyroid hormone receptor activation outside the liver. Roche has completed preclinical studies of the THR beta agonist. These studies demonstrated a rapid reduction of non-HDL cholesterol and the drug was shown to be synergistic with statins in animal studies. VIA will investigate the possibility of using the THR beta agonist in combination with statins for the treatment of hypercholesterolemia. In addition, in animal studies, insulin sensitization and glucose lowering were observed making this compound a possible treatment of
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
3. Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
6. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
9. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
10. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
11. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... INCLINE VILLAGE, Nev., May 6, 2015 PDL BioPharma, ... results for the first quarter ended March 31, 2015. ... 2015 increased nine percent to $149.7 million from $136.8 ... the quarter ended March 31, 2015 included $127.8 million ... the Queen et al. patents, $11.4 million in net ...
(Date:5/6/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... three months ended March 31, 2015.  ... , Achieved quarterly product revenue of $0.44 million, ... first quarter of 2014; , Activated a prospective ...
(Date:5/6/2015)... , May 6, 2015  Integrative medicine interventions ... patient-reported outcomes for chronic pain, depression, and stress, ... by The Bravewell Collaborative . The findings ... Receiving Integrative Medicine Interventions Effectiveness Registry (PRIMIER), the ... Using data from PRIMIER , researchers found ...
Breaking Medicine Technology:PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2
... 11, 2011 ViroPharma Incorporated (Nasdaq: ... that Halozyme has granted ViroPharma an exclusive worldwide ... proprietary drug delivery platform using Halozyme,s recombinant human ... C1 esterase inhibitor. Additionally, Halozyme has agreed not to ...
... MELVILLE, N.Y., May 11, 2011 Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, medical and veterinary practitioners, ... 500 ranking of America,s Largest Corporations.  Henry Schein,s net ... has steadily climbed the Fortune 500 rankings over the past ...
Cached Medicine Technology:ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 2ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 3ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 4ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 5ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 6ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 7Henry Schein Ranks #317 in 2011 Fortune 500 Ranking of America's Largest Corporations 2
(Date:5/6/2015)... 06, 2015 Baptist Medical Center ... first in north Florida and southeast Georgia region ... latest innovation in total hip replacement surgery performed ... robotic arm that enables the accurate alignment and ... has offered MAKOplasty® partial knee resurfacing using the ...
(Date:5/6/2015)... TMG Health, the leading national provider ... Medicare Part D and Managed Medicaid markets, was one ... category at the BCI North America Awards, a program ... outstanding contribution of business continuity professionals and organizations living ... the USA and Canada. The North America Awards were ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of its ... applications on the market for iOS, Android, and Windows. Joe Toohey, ... and shared with viewers how this application walks users through recipes. ... good navigator people had to know how to read a map? ... navigator. Well what if people could “GPS” their way through a ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Marketing ... #1 ranked international water, sanitation and hygiene nonprofit by ... communities across the world and it brings our agency ... CEO of Marketing Maven. “The ongoing relationship between ... available for people to learn about and support the ...
(Date:5/6/2015)... 06, 2015 Anitha Nallari, MD ... Oncology Consultants, Inc. in Columbus, OH. Dr. Nallari will ... special focus in breast cancer, lung cancer, GI and gallbladder ... well as benign hematology. , Dr. Anitha Nallari ... by the American Board of Internal Medicine. She completed her ...
Breaking Medicine News(10 mins):Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3
... The University of North Carolina at Chapel Hill School ... Robert Wood Johnson Foundation (RWJF) to explore how interactive ... health. , UNC joins 11 other research teams supported ... Research, an RWJF national program established to strengthen the ...
... whet men,s sexual appetite. But stimulating new research in ... meets the eye. A recent study shows that men ... gratificationeven when they were making decisions about money, soda, ... DeWitte, and Luk Warlop (KULeuven, Belgium) found that the ...
... to Rally Residents to Eat Right, Move More ... and Milk Their Diets, KANSAS ... and downs of different fad diets -- which seem to go in and ... out of three Americans -- including 23 percent of Kansas City,residents -- remain ...
... finds 13.7 million without coverage, mostly because of cost , , ... adults without health insurance rose again in 2006, so 38 ... graduates will spend some time uninsured in the year after ... since 2003, and every year we,ve done the study, the ...
... Completed, WASHINGTON, May 30 The Department of,Veterans ... to,veterans potentially identified as being ill or injured from ... begin targeting over 500,000 OEF-OIF veterans who have been,discharged ... health care., "We promised to reach out to ...
... 30 On June 5th at the annual ... vote for the,second year on a shareowner proposal ... The resolution received 42% last year., Walden ... on,integrating environmental, social and governance factors into the,investment ...
Cached Medicine News:Health News:UNC health researchers explore how to take interactive video games to the next level 2Health News:UNC health researchers explore how to take interactive video games to the next level 3Health News:Message to Kansas City, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Kansas City, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:More Young People Going Without Health Insurance 2Health News:More Young People Going Without Health Insurance 3Health News:VA Begins Next Phase of Combat Vet Outreach 2
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
The VersaStep™ 5 mm and VersaStep™ PLUS Reposable system components for creating each access port are supplied in separate packages....
... Long Instrument for applications in ... Plus Long Instrument with 150mm ... endoscopic entry device that has ... is used to establish entry ...
... Step™ and Mini Step™ device components are supplied ... Single Use System is supplied sterile in 2/3, ... in various configurations and combinations. They are used ... needle and the Step™ radially Expandable Sleeve. The ...
Medicine Products: